Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Track income, expenses, savings, and debt payments to gain a clear view of your financial health and progress.
16,643 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Start your week with anticipation and a sharper nose for risk. These monday reads pull back the curtain on real estat...
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
AI-first cloud services are redefining how businesses run. This article breaks down the neocloud revolution here. thi...
American Express has fallen notably in 2026, prompting questions about whether the drop makes it a bargain. This arti...
Are you debating whether to hold or sell JD.com stock? This jd.com stock analysis: sell? guide breaks down the busine...
SpaceX's IPO spark has investors buzzing, but Warren Buffett would never chase hype without a moat and predictable ca...
Fans dream of owning a piece of their favorite team. When a high-profile artist says they want a real stake rather th...
Shiba Inu dropped in double digits for a short window and then settled. This guide explains why shiba sank more than ...
Investing in Broadcom means weighing powerful data-center demand against semiconductor cycles. This guide breaks down...
A spike in revenue can grab headlines, but it rarely tells the full investment story. Here’s why super micro computer...
A large open-market sale by Indivior's Chief Scientific Officer sparked questions about future risk and long-term val...